Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2026 May 6;75(6):164. doi: 10.1007/s00262-026-04407-x

Correction: Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy

Kübra Canaslan 1, Fatemeh Moeini Nia 2, Maria Baez 3, Hassan Abolhassani 4, Natalie Ridge 5, Maroun Bou Zerdan 6, Jennifer Marks 7, Hussain Rangoonwala 8, Behnaz Jahanbin 9, Amir Hossein Emami 10, Katie O’Reilly 11, Yesim Gökmen-Polar 12, Sunil S Badve 12, Chunwei Xu 13, Yue Hao 13, Aparna Sharma 14, Swasthik Upadhya 15, Francoise Galateau Salle 16, Kelsey Pan 6, Badi El Osta 6, Dong M Shin 6, Fatemeh Ardeshir-larijani 6,✉
PMCID: PMC13149698  PMID: 42089900

Correction to: Cancer Immunology, Immunotherapy (2026) 75:110 10.1007/s00262-026-04311-4

In the original version of this article, the author’s name Badi El Osta was incorrectly written as Badi El Olsta.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES